Departamento de Obstetrícia e Ginecologia - FM/MOG

O Departamento de Obstetrícia e Ginecologia da Faculdade de Medicina da Universidade de São Paulo (FMUSP) desenvolve pesquisas e dedica-se à formação de profissionais da área gineco-obstétrica. Conta com comissões específicas que cuidam da avaliação de projetos, fomento, aspectos bioéticos e éticos em suas execuções e acompanhamentos. Tais atividades são exercidas no âmbito interno da Clínica e também das Instituições maiores (Faculdade e Hospital).

Além disso, a Disciplina de Ginecologia mantém um dos Laboratórios de Investigação Médica (LIM-59), que reúne um potencial bastante grande e seleto de recursos bio-tecnológicos e material humano consorciados; bem como sua utilização compartilhada, alavancando pesquisas que apresentariam dificuldade muito grande na sua execução isolada.

Site oficial: http://ginecousp.blogspot.com/

Browse

Recent Submissions

  1. MicroRNA-210-3p Regulates Endometriotic Lesion Development by Targeting IGFBP3 in Baboons and Women with Endometriosis (vol 30, pg 2932, 2023)

    REPRODUCTIVE SCIENCES, v.31, n.3, p.857-857, 2024

  2. A closer look at heterotopic sites of pleomorphic adenoma, particularly in women: fide, sed cui vide?

    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.70, n.2, article ID e20231193, 2p, 2024

  3. Low back pain, pelvic pain, and associated factors in type 1 diabetic pregnant women

    CLINICS, v.79, article ID 100325, 5p, 2024

    Introduction: Pregnancy and diabetes mellitus promote several musculoskeletal changes predisposing this population to complaints of Lower Back (LB) and Pelvic Pain (PP). Objective: To assess the frequency of LB and PP and associated factors in type 1 Diabetic (DM1) pregnant women. Method: An obse...

  4. Autologous heterotopic fresh ovarian graft: technique description

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, v.33, n.11, p.1825-1826, 2023

  5. Visual Analogue Scale Cut-off Point of Seven Represents Poor Quality of Life in Patients with Endometriosis

    REPRODUCTIVE SCIENCES, v.31, n.4, p.1146-1150, 2024

    Establishing objective criteria to assess endometriosis symptoms is crucial in defining therapeutic strategies. The visual analogue scale (VAS) is the most used system to enhance the accuracy and reduce the subjectivity of pain assessment, and symptoms of endometriosis are considered severe when ...

  6. Granulosa cells and follicular development: a brief review (vol 69, e20230175, 2023)

    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.69, n.12, article ID e20230175, 1p, 2023

  7. Data-driven, cross-disciplinary collaboration: lessons learned at the largest academic health center in Latin America during the COVID-19 pandemic

    FRONTIERS IN PUBLIC HEALTH, v.12, article ID 1369129, 15p, 2024

    Introduction The COVID-19 pandemic has prompted global research efforts to reduce infection impact, highlighting the potential of cross-disciplinary collaboration to enhance research quality and efficiency.Methods At the FMUSP-HC academic health system, we implemented innovative flow management r...

  8. Skin-sparing mastectomy for the treatment of breast cancer

    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, v.2023, n.3, article ID CD010993, p, 2023

    Background: Skin-sparing mastectomy (SSM) is a surgical technique that aims to maximize skin preservation, facilitate breast reconstruction, and improve cosmetic outcomes. Despite its use in clinical practice, the benefits and harms related to SSM are not well established. Objectives: To assess t...

  9. Adverse Perinatal Outcomes among Adolescent Pregnant Women Living with HIV: A Propensity-Score-Matched Study

    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, v.20, n.8, article ID 5447, p, 2023

    HIV infection and adolescent pregnancy are known to increase the risk of adverse perinatal outcomes. However, data are limited concerning the outcomes of pregnancies among adolescent girls living with HIV. This retrospective propensity-score matched study aimed to compare adverse perinatal outcom...

  10. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: Updated survival results of the randomized, phase 3 study DESTINY-Breast03

    CANCER RESEARCH, v.83, n.5, suppl.S, 2023